Russia’s “Sputnik-V” COVID-19 vaccine created an antibody response in all participants in early-stage trials, according to results published on Friday by The Lancet medical journal that was praised by Moscow as an answer to its critics.
The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants producing antibodies to the new coronavirus and no severe side effects, The Lancet said.
“The two 42-day trials – including 38 healthy adults each – did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” The Lancet said.
“Large, long-term trials including a placebo comparison and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection,” it said.
According to forecast figures in the annual infrastructure indicators report, in 2023, the number of…
Several migrants of different nationalities died in the sinking of a boat on the night…
The Prosecutor's Office of the Manouba Court of First Instance authorized, Saturday, the arrest of…
Intelligence units from the National Guard districts of Ghardimaou, Tabarka, Mater, Sbeitla and Grombalia, with…
Iran's Interior Minister Ahmed Vahidi confirmed that a helicopter in the convoy carrying President Ebrahim…
A helicopter carrying Iran's President Ebrahim Raisi and several officials, including Foreign Minister Hossein Amir-Abdollahian,…
This website uses cookies.